Call for proposals on the European Hub for vaccine development (HERA) - CP-g-24-10

This program is designed for consortia of vaccine developers, including public and industrial organizations, operating within the European Union. Its primary goal is to bolster Europe's preparedness for health crises by fostering advanced vaccine development.

The program funds projects focused on the full spectrum of vaccine development, from research to large-scale manufacturing, specifically targeting public health needs and pandemic preparedness. It prioritizes the creation of a robust European vaccine development hub.

Financial support is provided in the form of grants, with a substantial budget allocated to foster vaccine development within the European Union, specifically for projects under the European Hub for vaccine development (HERA).

Applicants and beneficiaries must adhere to specific conditions for application, consortium formation, and general grant management as detailed in the comprehensive call documentation and associated EU regulations.

The application process for this call has concluded. Proposals were submitted through a single-stage procedure, followed by an evaluation phase with results communicated to applicants.

The funding program operates under a clear legal framework established by key European Union regulations, ensuring transparency and adherence to financial and health policy guidelines.